|
WO2019077163A2
|
|
Pharmaceutical device
|
|
EP3512505A1
|
|
Vildagliptin pharmaceutical compositions
|
|
EP3156048A1
|
|
Stable pharmaceutical composition of linagliptin in the form of immediate release tablets
|
|
WO2016107890A1
|
|
Stable pharmaceutical compositions comprising micafungin
|
|
EP3160450A1
|
|
Stable pharmaceutical compositions in the form of immediate release tablets
|
|
EP2949319A1
|
|
Pharmaceutical compositions comprising an active agent
|
|
EP2949318A1
|
|
Pharmaceutical compositions comprising racecadotril
|
|
EP2915526A1
|
|
Pharmaceutical compositions comprising anagrelide
|
|
EP2918268A1
|
|
Pharmaceutical compositions comprising an active agent
|
|
US2017080008A1
|
|
Stable pharmaceutical compositions of sofosbuvir
|
|
EP2913049A1
|
|
Stable pharmaceutical compositions
|
|
EP3102187A1
|
|
Stable pharmaceutical compositions containing sitagliptin in the form of immediate release tablets
|
|
US2016143925A1
|
|
Stable pharmaceutical compositions
|
|
WO2015052115A1
|
|
Stable pharmaceutical formulations of caspofungin
|
|
US2016287524A1
|
|
Pharmaceutical compositions comprising an active agent
|
|
EP2796130A2
|
|
Immediate release tablets of rasagiline hemitartrate
|
|
EP2764875A1
|
|
Process for preparing a stable pharmaceutical composition comprising dexketoprofen trometamol
|
|
WO2014033291A1
|
|
Pharmaceutical compositions comprising an active agent
|
|
EP2774605A1
|
|
Pharmaceutical composition comprising almotriptan malate having uniform drug distribution and potency
|
|
EP2764862A1
|
|
Immediate release tablets of rasagiline hemitartrate
|
